Basic information Safety Supplier Related

Resolvin D4

Basic information Safety Supplier Related

Resolvin D4 Basic information

Product Name:
Resolvin D4
Synonyms:
  • Resolvin D4
  • 6,8,10,13,15,19-Docosahexaenoic acid, 4,5,17-trihydroxy-, (4S,5R,6E,8E,10Z,13Z,15E,17S,19Z)-
CAS:
1025684-60-9
MF:
C22H32O5
MW:
376.49
Mol File:
1025684-60-9.mol
More
Less

Resolvin D4 Chemical Properties

Boiling point:
609.2±55.0 °C(Predicted)
Density 
1.101±0.06 g/cm3(Predicted)
storage temp. 
Store at -20°C
solubility 
DMF: 50 mg/ml; Ethanol: 50 mg/ml; PBS (pH 7.2): 0.5 mg/ml
pka
4.50±0.10(Predicted)
More
Less

Resolvin D4 Usage And Synthesis

Uses

Resolvin D4 is a critical specialized proresolving mediator that limits NETosis in the formation of the clot, as well as regulating the rate of clot resolution.

Definition

ChEBI: Resolvin D4 is a member of the class of resolvins that is (6E,8E,10Z,13Z,15E,19Z)-docosahexaenoic acid carrying three hydroxy substituents at positions 4, 5 and 17 (the 4S,5R,17S-stereoisomer). It has a role as an anti-inflammatory agent and a human xenobiotic metabolite. It is a resolvin, a secondary allylic alcohol, a triol and a hydroxy polyunsaturated fatty acid.

in vivo

Resolvin D4 (RvD4, 10?ng/mouse) decreases percent of PMN, giving ~31% reduction at 4 hours[1].
Resolvin D4 (RvD4, 10?ng/mouse) modulates the severity of thrombo-inflammatory disease in vivo and improves thrombus resolution[2].

Animal Model:6-8-week-old male FVB mice (a self-limited bacterial inoculation (105 c.f.u) into the dorsal pouch)[1].
Dosage:200?ng/mouse (saline containing 0.01% EtOH).
Administration:I.P..
Result:Gave lower PMN levels in the cavity in mice treated with RvD4.
Significantly lowered bacterial counts when compared to vehicle control.
Stopped leukocyte influx to the site of infection in the dorsal pouch cavity as well as the inflammation-initiating eicosanoids by reducing levels of PGD2 and LTB4.
Animal Model:Thrombus-bearing mice[2].
Dosage:3 μg.
Administration:IV via tail vein injection on day 1 and day 4 after IVC stenosis.
Result:Accelerated venous thrombus resolution in mice.

Resolvin D4Supplier

Shanghai Hongye Biotechnology Co. Ltd
Tel
400-9205774
Email
sales@glpbio.cn
ChemeGen(Shanghai) Biotechnology Co.,Ltd.
Tel
18818260767
Email
sales@chemegen.com
Shanghai Universal Biotech Co.,Ltd
Tel
15921930842 15921930842
Email
yh-wang@univ-bio.com
Shanghai Yifei Biotechnology Co. , Ltd.
Tel
021-65675885 18964387627
Email
customer_service@efebio.com
TargetMol Chemicals Inc.
Tel
15002134094
Email
marketing@targetmol.cn